Skip to main content
. 2012 Aug 7;2(8):769–776. doi: 10.7150/thno.4690

Fig 2.

Fig 2

(A) In vivo NIR fluorescence imaging of U87 MG tumor-bearing mice immediately after tail vein injection of cRGD-NIR QD bioconjugates (a non-injected mouse used as blank control); (B) NIR imaging-guided surgery performed 48 h after injection; and (C) the solid tumor precisely removed.